Detail akcie Vivos Therap Rg online

Business Summary: Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Vivos Therapeutics Inc revenues increased 20% to $13.6M. Net loss increased 72% to $14.3M. Revenues reflect Sleep testing services segment increase from $954K to $3.6M, Center revenue segment increase of 68% to $2.2M. Higher net loss reflects General and administrative increase of 42% to $19.2M (expense), Other expense increase from $41K to $846K (expense).